Gemcitabine plus concurrent irreversible electroporation vs gemcitabine alone for locally advanced pancreatic cancer

Table 5 Adverse reactions after treatment

Adverse event	GEM + IRE group (n = 33)			GEM group (n = 35)
Grade	I/II	III	IV	I/II	III	IV
Toxicity
Hypoalbuminemia	5	0	0	3	0	0
Lymphopenia	2	0	0	1	0	0
Hemoglobin reduction	3	0	0	2	0	0
Neutropenia	1	0	0	0	0	0
Thrombocytopenia	2	0	0	3	0	0
Vomiting	2	0	0	3	0	0
Hypokalemia	1	0	0	1	0	0
Diarrhea	2	0	0	1	0	0
Complications
Pancreatitis	0	2	0	0	0	0
Ascites	2	0	0	4	0	0
Bleeding from duodenal ulcer	0	1	0	0	0	0
Portal vein thrombosis	1	0	0	3	0	0
Loss of appetite	2		0	1	0	0
Gastroparesis	1	0	0	1	0	0
Abdominal pain	2	0	0	2	2	0

IRE: Irreversible electroporation; GEM: Gemcitabine.